OMNI® Surgical System for Microinvasive Glaucoma Surgery combines two distinct angle procedures – ab interno trabeculotomy (or goniotomy involving the opening of trabecular meshwork and inner walls of Schlemm’s canal) and transluminal viscoelastic delivery (involving dilation of the aqueous outflow canal). It is the only MIGS device that allows surgeons to target all three points of aqueous humor outflow resistance – trabecular meshwork, Schlemm’s canal and distal collector channels. It is designed to improve the aqueous outflow to better lower the intraocular pressure and reduce the need for medications.

The OMNI was FDA approved in 2018 as a delivery system for a procedure that has been used for the past 80 years. We have been using the goniotomy procedure specifically to help glaucoma in babies and children who can be born with a clogged drainage system in their eye.

Surgery on the angle of the eye is also called a canaloplasty and allows fluid from the eye to better flow into the eye’s drainage channel (called Schlemm’s Canal). When successful, this procedure will lower the pressure in your eye, minimizing the risk of further vision loss from glaucoma